Delivery and targeting of nanoparticles into hair follicles

Therapeutic Delivery

Volumn 5, Issue 9, 2014, Pages 991-1006

  Fang, Chia Lang ^a,b   Aljuffali, Ibrahim A ^c   Li, Yi Ching ^d,e   Fang, Jia You ^d,e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLODEXTRIN DERIVATIVE; DIPHENCYPRONE; GOLD NANOPARTICLE; IMIQUIMOD; LIPOSOME; MINOXIDIL; NANOCARRIER; NANOCRYSTAL; NANOPARTICLE; OVALBUMIN; POLYMER; QUANTUM DOT; RETINOIC ACID; RETINOL ACETATE; SILICON DIOXIDE; SOLID LIPID NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; ZINC OXIDE NANOPARTICLE; DRUG; DRUG CARRIER; DRUG DOSAGE FORM;

ACNE; ALOPECIA; ALOPECIA AREATA; COMEDO; DNA IMMUNIZATION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TARGETING; FOLLICULITIS; FURUNCULOSIS; HAIR; HAIR FOLLICLE; HAIR GROWTH; HAIR ROOT; HIRSUTISM; HYPERTRICHOSIS; IMMUNIZATION; IMPETIGO; MALE TYPE ALOPECIA; NANOTECHNOLOGY; NONHUMAN; PHYSIOLOGICAL PROCESS; REVIEW; SCALP HAIR; SEBORRHEIC DERMATITIS; SKIN ABSCESS; SKIN ABSORPTION; SKIN DISEASE; TARGET CELL; TRANSCUTANEOUS IMMUNIZATION; ANIMAL; CHEMISTRY; DRUG DOSAGE FORM; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; METABOLISM; NANOMEDICINE; PHARMACEUTICS; PROCEDURES;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HAIR FOLLICLE; HUMANS; NANOMEDICINE; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; SKIN ABSORPTION; TECHNOLOGY, PHARMACEUTICAL;

EID: 84908609938     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/TDE.14.61     Document Type: Review

References (93)

1. Darlenski R, Fluhr JW. Influence of skin type, race, sex, and anatomic location on epidermal barrier function. Clin. Dermatol. 30, 269-273 (2012)
2. Hadgraft J. Modulation of the barrier function of skin. Skin Pharmacol. Appl. Skin Physiol. 14 (Suppl. 1), 72-81 (2001). • Summarizes the methods for overcoming skin barrier function.
3. Patzelt A, Lademann J. Drug delivery to hair follicles. Expert Opin. Drug Deliv. 10, 787-797 (2013). •• A complete review of topical drug delivery via hair follicles.
4. Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J. Invest. Dermatol. 123, 168-176 (2004).
5. Blume-Peytavi U, Vogt A. Human hair follicle: reservoir function and selective targeting. Br. J. Dermatol. 165 (Suppl. 2), 13-17 (2011). •• The introduction of follicles as a target for selective penetration.
6. Grice JE, Ciotti S, Weiner N, Lockwood P, Cross SE, Roberts MS. Relative uptake of minoxidil into appendages and stratum corneum and permeation through human skin in vitro. J. Pharm. Sci. 99, 712-718 (2010).
7. Shubayev VI, Pisanic TR, Jin S. Magnetic nanoparticles for theragnostics. Adv. Drug Deliv. Rev. 61, 467-477 (2009).
8. Kim JS, Yoon TJ, Yu KN et al. Cellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cells. J. Vet. Sci. 7, 321-326 (2006).
9. Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 59, 427-443 (2007). • Lipid nanoparticles used for delivering drug into skin.
10. Souto EB, Almeida AJ, Müller RH. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: structure, protection and skin effects. J. Biomed. Nanotechnol. 3, 317-331 (2007).
11. Chen H, Chang X, Du D et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Control. Release 110, 296-306 (2006).
12. Smijs TGM, Bouwstra JA. Focus on skin as a possible port of entry for solid nanoparticles and the toxicological impact. J. Biomed. Nanotechnol. 6, 469-484 (2010).
13. Frum Y, Bonner MC, Eccleston GM, Meidan VM. The influence of drug partition coefficient on follicular penetration: in vitro human skin studies. Eur. J. Pharm. Sci. 30, 280-287 (2007). • The examination of the effect of drug lipophilicity on follicular delivery.
14. Wosicka H, Cal K. Targeting to the hair follicles: current status and potential. J. Dermatol. Sci. 57, 83-89 (2010).
15. Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J. Variations of hair follicle size and distribution in different body sites. J. Invest. Dermatol. 122, 14-19 (2004).
16. Patzelt A, Knorr F, Blume-Peytavi U, Sterry W, Lademann J. Hair follicles, their disorders and their opportunities. Drug Discov. Today Dis. Mech. 5, 173-181 (2008).
17. Camera E, Ludovici M, Galante M, Sinagra JL, Picardo M. Comprehensive analysis of the major lipid classes in sebum by rapid resolution high-performance liquid chromatography and electrospray mass spectrometry. J. Lipid Res. 51, 3377-3388 (2010).
18. Huang ZR, Lin YK, Fang JY. Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. Molecules 14, 540-554 (2009).
19. Lee J, Tumbar T. Hairy tale of signaling in hair follicle development and cycling. Semin. Cell Dev. Biol. 23, 906-916 (2012).
20. Stenn KS, Paus R. Controls of hair follicle cycling. Physiol. Rev. 81, 449-494 (2001).
21. Lademann J, Knorr F, Richter H et al. Hair follicles-An efficient storage and penetration pathway for topically applied substances. Skin Pharmacol. Physiol. 21, 150-155 (2008).
22. Otberg N, Patzelt A, Rasulev U et al. The role of hair follicles in the percutaneous absorption of caffeine. Br. J. Clin. Pharmacol. 65, 488-492 (2008).
23. Blume-Peytavi U, Massoudy L, Patzelt A et al. Follicular and perctaneous penetration pathways of topically applied minoxidil foam. Eur. J. Pharm. Biopharm. 76, 450-453 (2010).
24. Liu X, Grice JE, Lademann J et al. Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man. Br. J. Clin. Pharmacol. 72, 768-774 (2011).
25. Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 59, 427-443 (2007).
26. Lademann J, Richter H, Meinke MC et al. Drug delivery with topically applied nanoparticles: science fiction or reality? Skin Pharmacol. Physiol. 26, 227-233 (2013). • The possible mechanisms of nanoparticle penetration into skin.
27. Lee WR, Shen SC, Aljuffali IA, Li YC, Fang JY. Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation. Pharm. Res. 31, 382-393 (2014).
28. Papakostas D, Rancan F, Sterry W, Blume-Peytavi U, Vogt A. Nanoparticles in dermatology. Arch. Dermatol. Res. 303, 533-550 (2011).
29. Lademann J, Richter H, Schanzer S et al. Penetration and storage of particles in human skin: perspectives and safety aspects. Eur. J. Pharm. Biopharm. 77, 465-468 (2011).
30. Chin EY. Androgenetic alopecia (male pattern hair loss) in the United States: what treatments should primary care providers recommend? J. Am. Assoc. Nurse Pract. 25, 395-401 (2013).
31. Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009. J. Invest. Dermatol. doi: 10.1038/jid.464 (2013) (2013).
32. Krause K, Foitzik K. Biology of the hair follicle: the basics. Semin. Cutan. Med. Surg. 25, 2-10 (2006).
33. Castro GA, Oliveira CA, Machecha GAB, Ferreira LAM. Comedolytic effect and reduced skin irritation of a new formulation of all-trans retinoic acid-loaded solid lipid nanoparticles for topical treatment of acne. Arch. Dermatol. Res. 303, 513-520 (2011).
34. Ourique AF, Melero A, de Bona da Silva C et al. Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine. Eur. J. Pharm. Biopharm. 79, 95-101 (2011).
35. Lin CH, Fang YP, Al-Suwayeh SA, Yang SY, Fang JY. Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment. Biol. Pharm. Bull. 36, 276-286 (2013).
36. Nakatsuji T, Kao MC, Fang JY et al. Antimicrobial property of lauric acid against Propionibacterium acnes : its therapeutic potential for inflammatory acne vulgaris. J. Invest. Dermatol. 129, 2480-2488 (2009).
37. Taglietti M, Hawkins CN, Rao J. Novel topical drug delivery systems and their potential use in acne vulgaris. Skin Ther. Lett. 13, 6-8 (2008).
38. Iwatsuki K, Yamasaki O, Morizane S, Oono T. Staphylococcal cutaneous infections: invasion, evasion and aggression. J. Dermatol. Sci. 42, 203-214 (2006).
39. Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J. Control. Release 99, 53-62 (2004).
40. Zhang LW, Monteiro-Riviere NA. Use of confocal microscopy for nanoparticle drug delivery through skin. J. Biomed. Opt. 18, 061214 (2013).
41. Wu X, Price GJ, Guy RH. Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin. Mol. Pharm. 6, 1441-1448 (2009).
42. Wu X, Griffin P, Price GJ, Guy RH. Preparation and in vitro evaluation of topical formulations based on polystyrene-poly-2-hydroxyl methacrylate nanoparticles. Mol. Pharm. 6, 1449-1456 (2009).
43. Kimura E, Kawano Y, Todo H, Ikarashi Y, Sugibayashi K. Measurement of skin permeation/penetration of nanoparticles for their safety evaluation. Biol. Pharm. Bull. 35, 1476-1486 (2012).
44. Lademann J, Richter H, Teichmann A et al. Nanoparticles-An efficient carrier for drug delivery into the hair follicles. Eur. J. Pharm. Biopharm. 66, 159-164 (2007).
45. Rancan F, Papakostas D, Hadam S et al. Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm. Res. 26, 2027-2036 (2009).
46. Patzelt A, Richter H, Knorr F et al. Selective follicular targeting by modification of the particle sizes. J. Control. Release 150, 45-48 (2011). • The influence of particulate size on follicular delivery.
47. Lademann J, Patzelt A, Richter H, Antoniou W, Sterry W, Knorr F. Determination of the cuticula thickness of human and porcine hairs and their potential influence on the penetration of nanoparticles into the hair follicles. J. Biomed. Opt. 14, 021014 (2009).
48. Morgen M, Lu GW, Du D et al. Targeted delivery of a poorly water-soluble compound to hair follicles using polymeric nanoparticle suspensions. Int. J. Pharm. 416, 314-322 (2011).
49. Bowe WP, Shalita AR. Effective over-the-counter acne treatments. Semin. Cutan. Med. Surg. 27, 170-176 (2008).
50. Arayachukeat S, Wanichwecharungruang SP, Tree-Udom T. Retinyl acetate-loaded nanoparticles: dermal penetration and release of the retinyl acetate. Int. J. Pharm. 404, 281-288 (2011).
51. Abdel-Mottaleb MMA, Moulari B, Beduneau A, Pellequer Y, Lamprecht A. Nanoparticles enhance therapeutic outcome in inflamed skin therapy. Eur. J. Pharm. Biopharm. 82, 151-157 (2012).
52. Sumian CC, Pitre FB, Gauthier BE, Bouclier M, Mordon SR. A new method to improve penetration depth of dyes into the follicular duct: potential application for laser hair removal. J. Am. Acad. Dermatol. 41, 172-175 (1999).
53. Toll R, Jacobi U, Richter H, Lademann J, Schäfer H, Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J. Invest. Dermatol. 123, 168-176 (2004).
54. Hansen S, Lehr CM. Nanoparticles for transcutaneous vaccination. Microb. Biotechnol. 5, 156-167 (2012).
55. Hansen S, Lehr CM. Transfollicular delivery takes root: the future for vaccine design? Expert Rev. Vaccines 13, 5-7 (2014).
56. Mittal A, Raber AS, Schäfer UF et al. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization. Vaccine 31, 3442-3451 (2013).
57. Teichmann A, Jacobi U, Ossadnik M et al. Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. J. Invest. Dermatol. 125, 264-269 (2005). • Introduction of differential stripping/cyanoacrylate techniques for measuring drug uptake in follicles.
58. Mattheolabakis G, Lagoumintzis G, Panagi Z, Papadimitriou E, Partidos CD, Avgoustakis K. Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responses. Int. J. Pharm. 385, 187-193 (2010).
59. Vogt A, Combadiere B, Hadam S et al. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J. Invest. Dermatol. 126, 1316-1322 (2006).
60. Mahe B, Vogt A, Liard C et al. Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J. Invest. Dermatol. 129, 1156-1164 (2009).
61. Saade F, Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Rev. Vaccines 11, 189-209 (2012).
62. Huang HN, Li TL, Chan YL, Chen CL, Wu CJ. Transdermal immunization with low-pressure-gene-gun mediated chitosan-based DNA vaccines against Japanese encephalitis virus. Biomaterials 30, 6017-6025 (2009).
63. Loomba L, Scarabelli T. Metallic nanoparticles and their medicinal potential. Part I: gold and silver colloids. Ther. Deliv. 4, 859-873 (2013).
64. Wang C, Gao X, Su X. In vitro and in vivo imaging with quantum dots. Anal. Bioanal. Chem. 397, 1397-1415 (2010).
65. Wang Y, Chen L. Quantum dots, lighting up the research and development of nanomedicine. Nanomed. Nanotechnol. Biol. Med. 7, 385-402 (2011).
66. Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, López-Quintela MA. Penetration of metallic nanoparticles in human full-thickness skin. J. Invest. Dermatol. 127, 1701-1712 (2007).
67. Lekki J, Stachura Z, Da¸broœ W et al. On the follicular pathway of percutaneous uptake of nanoparticles: ion microscopy and autoradiography studies. Nucl. Instrum. Methods Phys. Res. B 260, 174-177 (2007).
68. 2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol. Physiol. 22, 266-275 (2009).
69. Zvyagin AV, Zhao X, Gierden A, Sanchez W, Ross JA, Roberts MS. Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo. J. Biomed. Opt. 13, 064031 (2008).
70. Darvin ME, König K, Kellner-Hoefer M et al. Safety assessment by multiphoton fluorescence/second harmonic generation/hyper-Rayleigh scattering tomography of ZnO nanoparticles used in cosmetic products. Skin Pharmacol. Physiol. 25, 219-226 (2012).
71. Yu WW, Chang E, Falkner JC et al. Forming biocompatible and nonaggregated nanocrystals in water using amphiphilic polymers. J. Am. Chem. Soc. 129, 2871-2879 (2007).
72. Zhang LW, Yu WW, Colvin VL, Monteiro-Riviere NA. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 228, 200-211 (2008).
73. Tang L, Zhang CL, Song GM, Jin X, Xu ZW. In vivo skin penetration and metabolic path of quantum dots. Sci. China Life Sci. 56, 181-188 (2013).
74. 2 laser-assisted drug delivery. Lasers Surg. Med. 42, 113-122 (2010).
75. Lee WR, Shen SC, Al-Suwayeh SA, Yang HH, Li YC, Fang JY. Skin permeation of small-molecule drugs, macromolecules, and nanoparticles mediated by a fractional carbon dioxide laser: the role of hair follicles. Pharm. Res. 30, 792-802 (2013).
76. Fenske DB, Cullis PR. Liposomal nanomedicines, Exp. Opin. Drug Deliv. 5, 25-44 (2008).
77. Betz G, Imboden R, Imanidis G. Interaction of liposome formulations with human skin in vitro. Int. J. Pharm. 229, 117-129 (2001).
78. Zhang LW, Al-Suwayeh SA, Hung CF, Chen CC, Fang JY. Oil components modulate the skin delivery of 5-aminolevulinic acid and its ester prodrug from oil-in-water and water-in-oil nanoemulsions. Int. J. Nanomed. 6, 693-704 (2011).
79. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54, S131-155 (2002).
80. Liu KS, Wen CJ, Yen TC et al. Combined strategies of apomorphine diester prodrugs and nanostructured lipid carriers (NLCs) for efficient brain targeting. Nanotechnology 23, 095103 (2012).
81. Jung S, Otberg N, Thiede G et al. Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J. Invest. Dermatol. 126, 1728-1732 (2006).
82. Fang YP, Huang YB, Wu PC, Tsai YH. Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior. Eur. J. Pharm. Biopharm. 73, 391-398 (2009).
83. Li N, Peng LH, Chen X, Nakagawa S, Gao JQ. Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo. Int. J. Nanomed. 6, 3241-3250 (2011).
84. Desai P, Shah PP, Hayden P, Singh M. Investigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticles. Pharm. Res. 30, 1037-1049 (2013).
85. Lin YK, Al-Suwayeh SA, Leu YL, Shen FM, Fang JY. Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata. Pharm. Res. 30, 435-446 (2013).
86. Aljuffali IA, Sung CT, Shen FM, Huang CT, Fang JY. Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells. AAPS J. 16, 140-150 (2014).
87. Patlolla RR, Desai PR, Belay K, Singh MS. Translocation of cell penetrating peptide engrafted nanoparticles across skin layers. Biomaterials 31, 5598-5607 (2010).
88. Patel LN, Zaro JL, Shen WC. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm. Res. 24, 1977-1992 (2007).
89. Bonini M, Rossi S, Karlsson G, Almgren M, Lo Nostro P, Baglioni P. Self-assembly of β-cyclodextrin in water. Part 1: cryo-TEM and dynamic and static light scattering. Langmuir 22, 1478-1484 (2006).
90. Konrádsdóttir F, Ogmundsdóttir H, Sigurdsson V, Loftsson T. Drug targeting to the hair follicles: a cyclodextrin-based drug delivery. AAPS PharmSciTech 10, 266-269 (2009).
91. Slowing II, Trewyn BG, Giri S, Lin VSY. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv. Func. Mater. 17, 1225-1236 (2007).
92. Patzelt A, Richter H, Dähne L et al. Influence of the vehicle on the penetration of particles into hair follicles. Pharmaceutics 3, 307-314 (2011).
93. Rancan F, Gao Q, Graf C et al. Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. ACS Nano 6, 6829-6842 (2012).